APO Research
Talk to an analyst

APO RESEARCH · REPORT

Androgenic Alopecia Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Androgenic Alopecia Therapeutics Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchAndrogenic Alopecia Therapeutics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Androgenic Alopecia Therapeutics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Androgenic Alopecia Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Androgenic Alopecia Therapeutics Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Androgenic Alopecia Therapeutics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Androgenic Alopecia Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Androgenic Alopecia Therapeutics include Aclaris Therapeutics, Almirall, Astellas Pharma, BiologicsMD, Brickell Biotech, Cipla, Concert Pharmaceuticals, Reddy's Laboratories and RiverTown Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Androgenic Alopecia Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Androgenic Alopecia Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Androgenic Alopecia Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Androgenic Alopecia Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Androgenic Alopecia Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Androgenic Alopecia Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Androgenic Alopecia Therapeutics Segment by Company

Aclaris Therapeutics

Almirall

Astellas Pharma

BiologicsMD

Brickell Biotech

Cipla

Concert Pharmaceuticals

Reddy's Laboratories

RiverTown Therapeutics

GlaxoSmithKline

Merck

Johnson & Johnson

Sun Pharma

Androgenic Alopecia Therapeutics Segment by Type

Medicine

Surgery

Other

Androgenic Alopecia Therapeutics Segment by Application

Hospital

Clinic

Other

Androgenic Alopecia Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgenic Alopecia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androgenic Alopecia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgenic Alopecia Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Androgenic Alopecia Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Androgenic Alopecia Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgenic Alopecia Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medicine Major Player Table 3. Surgery Major Player Table 4. Other Major Player Table 5. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Clinic Major Player Table 8. Other Major Player Table 9. Androgenic Alopecia Therapeutics Industry Trends Table 10. Androgenic Alopecia Therapeutics Industry Drivers Table 11. Androgenic Alopecia Therapeutics Industry Opportunities and Challenges Table 12. Androgenic Alopecia Therapeutics Industry Restraints Table 13. Global Androgenic Alopecia Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Androgenic Alopecia Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Androgenic Alopecia Therapeutics Market Share by Region (2021-2026) Table 16. Global Androgenic Alopecia Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Androgenic Alopecia Therapeutics Market Share by Region (2027-2032) Table 18. Global Androgenic Alopecia Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Androgenic Alopecia Therapeutics Revenue Market Share by Players (2021-2026) Table 20. Global Androgenic Alopecia Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Androgenic Alopecia Therapeutics Key Players Headquarters & Area Served Table 22. Global Androgenic Alopecia Therapeutics Players, Product Type & Application Table 23. Global Androgenic Alopecia Therapeutics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Androgenic Alopecia Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Androgenic Alopecia Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Androgenic Alopecia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Androgenic Alopecia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Global Androgenic Alopecia Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Androgenic Alopecia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Androgenic Alopecia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2021-2026) Table 35. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2027-2032) Table 36. Aclaris Therapeutics Company Information Table 37. Aclaris Therapeutics Business Overview Table 38. Aclaris Therapeutics Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Aclaris Therapeutics Androgenic Alopecia Therapeutics Product Portfolio Table 40. Aclaris Therapeutics Recent Development Table 41. Almirall Company Information Table 42. Almirall Business Overview Table 43. Almirall Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Almirall Androgenic Alopecia Therapeutics Product Portfolio Table 45. Almirall Recent Development Table 46. Astellas Pharma Company Information Table 47. Astellas Pharma Business Overview Table 48. Astellas Pharma Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Astellas Pharma Androgenic Alopecia Therapeutics Product Portfolio Table 50. Astellas Pharma Recent Development Table 51. BiologicsMD Company Information Table 52. BiologicsMD Business Overview Table 53. BiologicsMD Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. BiologicsMD Androgenic Alopecia Therapeutics Product Portfolio Table 55. BiologicsMD Recent Development Table 56. Brickell Biotech Company Information Table 57. Brickell Biotech Business Overview Table 58. Brickell Biotech Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Brickell Biotech Androgenic Alopecia Therapeutics Product Portfolio Table 60. Brickell Biotech Recent Development Table 61. Cipla Company Information Table 62. Cipla Business Overview Table 63. Cipla Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Cipla Androgenic Alopecia Therapeutics Product Portfolio Table 65. Cipla Recent Development Table 66. Concert Pharmaceuticals Company Information Table 67. Concert Pharmaceuticals Business Overview Table 68. Concert Pharmaceuticals Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product Portfolio Table 70. Concert Pharmaceuticals Recent Development Table 71. Reddy's Laboratories Company Information Table 72. Reddy's Laboratories Business Overview Table 73. Reddy's Laboratories Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Reddy's Laboratories Androgenic Alopecia Therapeutics Product Portfolio Table 75. Reddy's Laboratories Recent Development Table 76. RiverTown Therapeutics Company Information Table 77. RiverTown Therapeutics Business Overview Table 78. RiverTown Therapeutics Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. RiverTown Therapeutics Androgenic Alopecia Therapeutics Product Portfolio Table 80. RiverTown Therapeutics Recent Development Table 81. GlaxoSmithKline Company Information Table 82. GlaxoSmithKline Business Overview Table 83. GlaxoSmithKline Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. GlaxoSmithKline Androgenic Alopecia Therapeutics Product Portfolio Table 85. GlaxoSmithKline Recent Development Table 86. Merck Company Information Table 87. Merck Business Overview Table 88. Merck Androgenic Alopecia Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Merck Androgenic Alopecia Therapeutics Product Portfolio Table 90. Merck Recent Development Table 91. Johnson & Johnson Company Information Table 92. Johnson & Johnson Business Overview Table 93. Johnson & Johnson Androgenic Alopecia Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Johnson & Johnson Androgenic Alopecia Therapeutics Product Portfolio Table 95. Johnson & Johnson Recent Development Table 96. Sun Pharma Company Information Table 97. Sun Pharma Business Overview Table 98. Sun Pharma Androgenic Alopecia Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sun Pharma Androgenic Alopecia Therapeutics Product Portfolio Table 100. Sun Pharma Recent Development Table 101. North America Androgenic Alopecia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Androgenic Alopecia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Androgenic Alopecia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Androgenic Alopecia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Androgenic Alopecia Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Androgenic Alopecia Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Androgenic Alopecia Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Androgenic Alopecia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Androgenic Alopecia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Androgenic Alopecia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Androgenic Alopecia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Androgenic Alopecia Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Androgenic Alopecia Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Androgenic Alopecia Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 115. China Androgenic Alopecia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 116. China Androgenic Alopecia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 117. China Androgenic Alopecia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 118. China Androgenic Alopecia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Androgenic Alopecia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Androgenic Alopecia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Androgenic Alopecia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Androgenic Alopecia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Androgenic Alopecia Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Androgenic Alopecia Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Androgenic Alopecia Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Androgenic Alopecia Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Androgenic Alopecia Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Androgenic Alopecia Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Androgenic Alopecia Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Androgenic Alopecia Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Androgenic Alopecia Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Androgenic Alopecia Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Androgenic Alopecia Therapeutics Image Figure 2. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Androgenic Alopecia Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medicine Image Figure 5. Surgery Image Figure 6. Other Image Figure 7. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Androgenic Alopecia Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Androgenic Alopecia Therapeutics Market Size (US$ Million) & (2021-2032) Figure 13. Global Androgenic Alopecia Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Androgenic Alopecia Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Androgenic Alopecia Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Androgenic Alopecia Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Androgenic Alopecia Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2021-2032) Figure 20. Global Androgenic Alopecia Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2021-2032) Figure 23. North America Androgenic Alopecia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032) Figure 25. North America Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032) Figure 26. North America Androgenic Alopecia Therapeutics Revenue Share by Country (2021-2032) Figure 27. United States Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Androgenic Alopecia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032) Figure 32. Europe Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032) Figure 33. Europe Androgenic Alopecia Therapeutics Revenue Share by Country (2021-2032) Figure 34. Germany Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Androgenic Alopecia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032) Figure 44. China Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032) Figure 45. Asia Androgenic Alopecia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032) Figure 47. Asia Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032) Figure 48. Asia Androgenic Alopecia Therapeutics Revenue Share by Region (2021-2032) Figure 49. Japan Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Androgenic Alopecia Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032) Figure 57. SAMEA Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032) Figure 58. SAMEA Androgenic Alopecia Therapeutics Revenue Share by Country (2021-2032) Figure 59. Brazil Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Androgenic Alopecia Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Surgery
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Aclaris Therapeutics
  • Almirall
  • Astellas Pharma
  • BiologicsMD
  • Brickell Biotech
  • Cipla
  • Concert Pharmaceuticals
  • Reddy's Laboratories
  • RiverTown Therapeutics
  • GlaxoSmithKline
  • Merck
  • Johnson & Johnson
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Androgenic Alopecia Therapeutics Market by Type
  3. 1.2.1 Global Androgenic Alopecia Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medicine
  5. 1.2.3 Surgery
  6. 1.2.4 Other
  7. 1.3 Androgenic Alopecia Therapeutics Market by Application
  8. 1.3.1 Global Androgenic Alopecia Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Androgenic Alopecia Therapeutics Market Dynamics
  1. 2.1 Androgenic Alopecia Therapeutics Industry Trends
  2. 2.2 Androgenic Alopecia Therapeutics Industry Drivers
  3. 2.3 Androgenic Alopecia Therapeutics Industry Opportunities and Challenges
  4. 2.4 Androgenic Alopecia Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Androgenic Alopecia Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Androgenic Alopecia Therapeutics Growth Trends by Region
  3. 3.2.1 Global Androgenic Alopecia Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Androgenic Alopecia Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Androgenic Alopecia Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Androgenic Alopecia Therapeutics Revenue by Players
  2. 4.1.1 Global Androgenic Alopecia Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Androgenic Alopecia Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Androgenic Alopecia Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Androgenic Alopecia Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Androgenic Alopecia Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Androgenic Alopecia Therapeutics Players, Product Type & Application
  8. 4.5 Global Androgenic Alopecia Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Androgenic Alopecia Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Androgenic Alopecia Therapeutics Tier 1, Tier 2, and Tier 3
5 Androgenic Alopecia Therapeutics Market Size by Type
  1. 5.1 Global Androgenic Alopecia Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Androgenic Alopecia Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2021-2032)
6 Androgenic Alopecia Therapeutics Market Size by Application
  1. 6.1 Global Androgenic Alopecia Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Androgenic Alopecia Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aclaris Therapeutics
  2. 7.1.1 Aclaris Therapeutics Company Information
  3. 7.1.2 Aclaris Therapeutics Business Overview
  4. 7.1.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aclaris Therapeutics Androgenic Alopecia Therapeutics Product Portfolio
  6. 7.1.5 Aclaris Therapeutics Recent Developments
  7. 7.2 Almirall
  8. 7.2.1 Almirall Company Information
  9. 7.2.2 Almirall Business Overview
  10. 7.2.3 Almirall Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Almirall Androgenic Alopecia Therapeutics Product Portfolio
  12. 7.2.5 Almirall Recent Developments
  13. 7.3 Astellas Pharma
  14. 7.3.1 Astellas Pharma Company Information
  15. 7.3.2 Astellas Pharma Business Overview
  16. 7.3.3 Astellas Pharma Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Astellas Pharma Androgenic Alopecia Therapeutics Product Portfolio
  18. 7.3.5 Astellas Pharma Recent Developments
  19. 7.4 BiologicsMD
  20. 7.4.1 BiologicsMD Company Information
  21. 7.4.2 BiologicsMD Business Overview
  22. 7.4.3 BiologicsMD Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BiologicsMD Androgenic Alopecia Therapeutics Product Portfolio
  24. 7.4.5 BiologicsMD Recent Developments
  25. 7.5 Brickell Biotech
  26. 7.5.1 Brickell Biotech Company Information
  27. 7.5.2 Brickell Biotech Business Overview
  28. 7.5.3 Brickell Biotech Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Brickell Biotech Androgenic Alopecia Therapeutics Product Portfolio
  30. 7.5.5 Brickell Biotech Recent Developments
  31. 7.6 Cipla
  32. 7.6.1 Cipla Company Information
  33. 7.6.2 Cipla Business Overview
  34. 7.6.3 Cipla Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cipla Androgenic Alopecia Therapeutics Product Portfolio
  36. 7.6.5 Cipla Recent Developments
  37. 7.7 Concert Pharmaceuticals
  38. 7.7.1 Concert Pharmaceuticals Company Information
  39. 7.7.2 Concert Pharmaceuticals Business Overview
  40. 7.7.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product Portfolio
  42. 7.7.5 Concert Pharmaceuticals Recent Developments
  43. 7.8 Reddy's Laboratories
  44. 7.8.1 Reddy's Laboratories Company Information
  45. 7.8.2 Reddy's Laboratories Business Overview
  46. 7.8.3 Reddy's Laboratories Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Reddy's Laboratories Androgenic Alopecia Therapeutics Product Portfolio
  48. 7.8.5 Reddy's Laboratories Recent Developments
  49. 7.9 RiverTown Therapeutics
  50. 7.9.1 RiverTown Therapeutics Company Information
  51. 7.9.2 RiverTown Therapeutics Business Overview
  52. 7.9.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 RiverTown Therapeutics Androgenic Alopecia Therapeutics Product Portfolio
  54. 7.9.5 RiverTown Therapeutics Recent Developments
  55. 7.10 GlaxoSmithKline
  56. 7.10.1 GlaxoSmithKline Company Information
  57. 7.10.2 GlaxoSmithKline Business Overview
  58. 7.10.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GlaxoSmithKline Androgenic Alopecia Therapeutics Product Portfolio
  60. 7.10.5 GlaxoSmithKline Recent Developments
  61. 7.11 Merck
  62. 7.11.1 Merck Company Information
  63. 7.11.2 Merck Business Overview
  64. 7.11.3 Merck Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Merck Androgenic Alopecia Therapeutics Product Portfolio
  66. 7.11.5 Merck Recent Developments
  67. 7.12 Johnson & Johnson
  68. 7.12.1 Johnson & Johnson Company Information
  69. 7.12.2 Johnson & Johnson Business Overview
  70. 7.12.3 Johnson & Johnson Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Johnson & Johnson Androgenic Alopecia Therapeutics Product Portfolio
  72. 7.12.5 Johnson & Johnson Recent Developments
  73. 7.13 Sun Pharma
  74. 7.13.1 Sun Pharma Company Information
  75. 7.13.2 Sun Pharma Business Overview
  76. 7.13.3 Sun Pharma Androgenic Alopecia Therapeutics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sun Pharma Androgenic Alopecia Therapeutics Product Portfolio
  78. 7.13.5 Sun Pharma Recent Developments
8 North America
  1. 8.1 North America Androgenic Alopecia Therapeutics Revenue (2021-2032)
  2. 8.2 North America Androgenic Alopecia Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Androgenic Alopecia Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Androgenic Alopecia Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Androgenic Alopecia Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Androgenic Alopecia Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Androgenic Alopecia Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Androgenic Alopecia Therapeutics Revenue by Country
  11. 8.6.1 North America Androgenic Alopecia Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Androgenic Alopecia Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Androgenic Alopecia Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Androgenic Alopecia Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Androgenic Alopecia Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Androgenic Alopecia Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Androgenic Alopecia Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Androgenic Alopecia Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Androgenic Alopecia Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Androgenic Alopecia Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Androgenic Alopecia Therapeutics Revenue by Country
  11. 9.6.1 Europe Androgenic Alopecia Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Androgenic Alopecia Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Androgenic Alopecia Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Androgenic Alopecia Therapeutics Revenue (2021-2032)
  2. 10.2 China Androgenic Alopecia Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Androgenic Alopecia Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Androgenic Alopecia Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Androgenic Alopecia Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Androgenic Alopecia Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Androgenic Alopecia Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Androgenic Alopecia Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Androgenic Alopecia Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Androgenic Alopecia Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Androgenic Alopecia Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Androgenic Alopecia Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Androgenic Alopecia Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Androgenic Alopecia Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Androgenic Alopecia Therapeutics Revenue by Country
  11. 11.6.1 Asia Androgenic Alopecia Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Androgenic Alopecia Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Androgenic Alopecia Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Androgenic Alopecia Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Androgenic Alopecia Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Androgenic Alopecia Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Androgenic Alopecia Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Androgenic Alopecia Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Androgenic Alopecia Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Androgenic Alopecia Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Androgenic Alopecia Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Androgenic Alopecia Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Androgenic Alopecia Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Androgenic Alopecia Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Androgenic Alopecia Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Androgenic Alopecia Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst